SP 27
New drugs for low grade lymphoproliferative diseases
Argiris Symeonidis
Lido
2204
Vezesque se leu este artigo
1057
Total PDF
1147
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 6 | 21 | 9 | 30 |
| 2025 5 | 39 | 15 | 54 |
| 2025 4 | 36 | 12 | 48 |
| 2025 3 | 37 | 11 | 48 |
| 2025 2 | 25 | 13 | 38 |
| 2025 1 | 35 | 17 | 52 |
| 2024 12 | 23 | 14 | 37 |
| 2024 11 | 28 | 19 | 47 |
| 2024 10 | 12 | 16 | 28 |
| 2024 9 | 32 | 20 | 52 |
| 2024 8 | 23 | 20 | 43 |
| 2024 7 | 16 | 16 | 32 |
| 2024 6 | 25 | 23 | 48 |
| 2024 5 | 32 | 19 | 51 |
| 2024 4 | 24 | 15 | 39 |
| 2024 3 | 17 | 13 | 30 |
| 2024 2 | 21 | 18 | 39 |
| 2024 1 | 23 | 28 | 51 |
| 2023 12 | 19 | 23 | 42 |
| 2023 11 | 31 | 36 | 67 |
| 2023 10 | 16 | 25 | 41 |
| 2023 9 | 21 | 34 | 55 |
| 2023 8 | 13 | 7 | 20 |
| 2023 7 | 18 | 8 | 26 |
| 2023 6 | 28 | 23 | 51 |
| 2023 5 | 27 | 16 | 43 |
| 2023 4 | 14 | 4 | 18 |
| 2023 3 | 11 | 14 | 25 |
| 2023 2 | 12 | 9 | 21 |
| 2023 1 | 14 | 3 | 17 |
| 2022 12 | 13 | 16 | 29 |
| 2022 11 | 13 | 16 | 29 |
| 2022 10 | 18 | 12 | 30 |
| 2022 9 | 19 | 26 | 45 |
| 2022 8 | 17 | 18 | 35 |
| 2022 7 | 12 | 26 | 38 |
| 2022 6 | 10 | 13 | 23 |
| 2022 5 | 15 | 23 | 38 |
| 2022 4 | 9 | 24 | 33 |
| 2022 3 | 13 | 21 | 34 |
| 2022 2 | 15 | 17 | 32 |
| 2021 1 | 13 | 14 | 27 |
| 2021 12 | 15 | 18 | 33 |
| 2021 11 | 24 | 29 | 53 |
| 2021 10 | 22 | 22 | 44 |
| 2021 9 | 24 | 21 | 45 |
| 2021 8 | 28 | 29 | 57 |
| 2021 7 | 38 | 35 | 73 |
| 2021 6 | 14 | 23 | 37 |
| 2021 5 | 24 | 27 | 51 |
| 2021 4 | 20 | 35 | 55 |
| 2021 3 | 33 | 27 | 60 |
| 2021 2 | 18 | 20 | 38 |
| 2020 1 | 11 | 20 | 31 |
| 2020 12 | 7 | 11 | 18 |
| 2020 11 | 9 | 14 | 23 |
Mostrar tudo
